Beyond oncology: Selinexor’s journey into anti-inflammatory treatment and long-term management

MLA

Dan Li, et al. “Beyond Oncology: Selinexor’s Journey into Anti-Inflammatory Treatment and Long-Term Management.” Frontiers in Immunology, vol. 15, May 2024. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1398927.

APA

Dan Li, Hong Fang, Rong Zhang, Qian Xie, Yang Yang, & Lin Chen. (2024). Beyond oncology: Selinexor’s journey into anti-inflammatory treatment and long-term management. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1398927

Chicago

Dan Li, Hong Fang, Rong Zhang, Qian Xie, Yang Yang, and Lin Chen. 2024. “Beyond Oncology: Selinexor’s Journey into Anti-Inflammatory Treatment and Long-Term Management.” Frontiers in Immunology 15 (May). doi:10.3389/fimmu.2024.1398927.